Dalan Animal Health has a total of 26 patents globally, out of which 2 have been granted. Of these 26 patents, more than 88% patents are active. Europe is where Dalan Animal Health has filed the maximum number of patents, followed by United States of America. Parallelly, United States of
Karius has a total of 87 patents globally, out of which 29 have been granted. Of these 87 patents, more than 73% patents are active. United States of America is where Karius has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems
Invetx has a total of 57 patents globally, out of which 5 have been granted. Of these 57 patents, more than 92% patents are active. United States of America is where Invetx has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Australia. Parallelly, United States of
Ibex Biosciences has a total of 36 patents globally, out of which 1 has been granted. Of these 36 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ibex Biosciences. Ibex Biosciences
Centivax has a total of 31 patents globally, out of which 10 have been granted. Of these 31 patents, more than 67% patents are active. The United States of America is where Centivax has filed the maximum number of patents, followed by Europe and Hong Kong (S.A.R.). Parallelly, United States
Aulos Bioscience has a total of 18 patents globally, out of which 4 have been granted. Of these 18 patents, more than 59% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Aulos Bioscience. Aulos Bioscience
Microvascular Tissues has a total of 58 patents globally, out of which 33 have been granted. Of these 58 patents, more than 63% patents are active. United States of America is where Microvascular Tissues has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of
Kalivir Immunotherapeutics has a total of 71 patents globally, out of which no patent has been granted. Of these 71 patents, more than 92% patents are active. The United States of America is where Kalivir Immunotherapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United
Calidi Biotherapeutics has a total of 62 patents globally, out of which 28 have been granted. Of these 62 patents, more than 91% patents are active. The United States of America is where Calidi Biotherapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States
Mirror Biologics has a total of 67 patents globally, out of which 46 have been granted. Of these 67 patents, more than 86% patents are active. The United States of America is where Mirror Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.